Highlights
NASDAQ: TBIO       Translate Bio Inc
Last Price Today's Change   Day's Range   Trading Volume
14.87   -0.77 (4.92%)  14.16 - 17.12  687,219

Overview

 
Avg Volume (4 weeks):801,788
4 Weeks Range:13.25 - 21.95
4 Weeks Price Volatility (%):
18.62%
52 Weeks Range:6.80 - 21.95
52 Weeks Price Volatility (%):
53.27%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Transgenomic, Inc. is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical and biotechnology companies.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3156  2699  216  2889 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TOPS 0.225+0.073 
 AAL 18.59+1.87 
 SHIP 0.169+0.032 
 HTZ 2.57+1.07 
 LK 5.51+1.46 
 OAS 1.26+0.703 
 F 7.34+0.77 
 XSPA 2.37+0.47 
 GE 7.88+0.14 
 UAL 42.405+3.305 
Partners & Brokers